Bracco Affirms Cardiac PET Standard of Care

Bracco affirms the American Society of Nuclear Cardiology's (ASNC) position statement, which elevates cardiac positron emission tomography (PET) with myocardial blood flow (MBF) as the preferred standard for diagnosing coronary artery disease. As a market leader and pioneer in cardiac PET imaging for over three decades, Bracco supports this guideline. This endorsement reinforces the clinical value and diagnostic accuracy of PET imaging in cardiovascular care, promoting its wider adoption among healthcare providers.